Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial
Kimia Motlagh Asghari, Neda Dolatkhah, Hormoz Ayromlou, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Effects of Probiotics on Markers of Oxidative/Nitrosative Stress and Damage Associated with Inflammation in Non-Communicable Diseases: a Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Natanny Swerts Silva, Cláudio Daniel Cerdeira, Tiago Marques dos Reis, et al.
Research Square (Research Square) (2025)
Closed Access
Probiotics are beneficial for liver cirrhosis: a systematic review and meta-analysis of randomized control trials
Xing Yang, Langhuan Lei, Wei Shi, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 4
Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet
Theresa L. Montgomery, Daniel Peipert, Dimitry N. Krementsov
Immunological Reviews (2024) Vol. 325, Iss. 1, pp. 131-151
Open Access | Times Cited: 4
The role of the “gut microbiota-mitochondria” crosstalk in the pathogenesis of multiple sclerosis
Huan Tian, Dunbing Huang, Jiaqi Wang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Non-lactic acid bacteria probiotics isolated from intestine or various circumstances
Na‐Kyoung Lee, Hye Ji Jang, Hyun‐Dong Paik
Food Science and Biotechnology (2024) Vol. 33, Iss. 9, pp. 1997-2007
Closed Access | Times Cited: 1
The influence of aging and the microbiome in multiple sclerosis and other neurologic diseases
Naomi M. Fettig, Annie Pu, Lisa C. Osborne, et al.
Immunological Reviews (2024) Vol. 325, Iss. 1, pp. 166-189
Closed Access | Times Cited: 1
A Randomized Cross-Over Trial of Prebiotics and Probiotics in Multiple Sclerosis: Trial Feasibility, Supplement Tolerability and Symptom Abatement
Rebecca Straus Farber, Elizabeth Walker, Fatoumata Diallo, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 89, pp. 105762-105762
Closed Access | Times Cited: 1
A prospective pilot study of gut microbiome in cerebral vasospasm and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
Tomasz Klepinowski, Karolina Skonieczna‐Żydecka, Igor Łoniewski, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research
Alana Haussmann, Zsuzsanna H. McMahan, Elizabeth R. Volkmann
Current Opinion in Rheumatology (2024) Vol. 36, Iss. 6, pp. 401-409
Closed Access | Times Cited: 1
Thinking outside the brain: Gut microbiome influence on innate immunity within neurodegenerative disease
Andrea R. Merchak, MacKenzie L. Bolen, Malú G. Tansey, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00476-e00476
Open Access | Times Cited: 1
16S rRNA gene amplicon-based gut microbiome signature in cerebral vasospasm and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: A prospective nested case-control pilot study
Tomasz Klepinowski, Karolina Skonieczna‐Żydecka, Igor Łoniewski, et al.
Research Square (Research Square) (2024)
Closed Access
Impact of Lifestyle Interventions on Multiple Sclerosis: Focus on Adipose Tissue
Marta Mallardo, F Mazzeo, Giacomo Lus, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3100-3100
Open Access
Antioxidant Therapies in the Treatment of Multiple Sclerosis
Félix Javier Jiménez‐Jiménez, Hortensia Alonso‐Navarro, Paula Salgado-Cámara, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1266-1266
Open Access
Effect of Lactobacillus Reuteri in Children with Chronic Functional Constipation: A Double-Blind Randomized Clinical Trial
Kumars Pourrostami, Masoud Aman Mohammadi, Ali Forgani, et al.
Research Square (Research Square) (2024)
Open Access
Gut Microbiota-Immune System Interactions in Health and Neurodegenerative Diseases: Insights into Molecular Mechanisms and Therapeutic Applications
Rengasamy Balakrishnan, Seungha Kang, Ji Yeon Lee, et al.
Aging and Disease (2024)
Open Access
Effects of Probiotics on Neurodegenerative Disease-Related Symptoms and Systemic Inflammation: A Systematic Review
Fengya Zhu, Shao Yin, Yuan Wang, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 5941-5958
Open Access
Pyroptosis the Emerging Link Between Gut Microbiota and Multiple Sclerosis
Hua Fan, Ruile Shen, Junqiang Yan, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 6145-6164
Open Access
The Link Between Dysbiosis, Inflammation, Oxidative Stress, and Asthma—The Role of Probiotics, Prebiotics, and Antioxidants
Paulina Kleniewska, Rafał Pawliczak
Nutrients (2024) Vol. 17, Iss. 1, pp. 16-16
Open Access
Page 1

Scroll to top